101 related articles for article (PubMed ID: 83410)
1. [Studies on antitumor activities and pulmonary toxicity of pepleomycin sulfate (NK631) (author's transl)].
Ebihara K; Ekimoto H; Itchoda Y; Abe F; Inoue H; Aoyagi S; Yamashita T; Koyu A; Takahashi K; Yoshioka O; Matsuda A
Jpn J Antibiot; 1978 Dec; 31(12):872-85. PubMed ID: 83410
[TBL] [Abstract][Full Text] [Related]
2. [Studies on organ distribution, absorption and excretion of pepleomycin sulfate (NK631) (author's transl)].
Abe F; Yoshioka O; Ebihara K; Koyu A; Suzuki H; Inoue H; Kodaka A; Matsuda A
Jpn J Antibiot; 1978 Dec; 31(12):886-94. PubMed ID: 83411
[TBL] [Abstract][Full Text] [Related]
3. [Toxicological studies of pepleomycin sulfate. V. Short term intermittent toxicity in dogs (author's transl)].
Hashimoto Y; Yamashita T; Koyu A; Ebihara K; Suzuki H; Kumagai M; Yoshioka O; Matsuda A
Jpn J Antibiot; 1978 Dec; 31(12):837-58. PubMed ID: 83408
[TBL] [Abstract][Full Text] [Related]
4. [Toxicological studies on pepleomycin sulfate (NK631). III. Subacute toxicity of pepleomycin in dogs (author's transl)].
Ito K; Handa J; Irie Y; Ezura H; Kumagai M; Irie Y; Suzuki A; Miyamoto K; Yamashita T; Tsubosaki M; Matsuda A; Konoha N
Jpn J Antibiot; 1978 Dec; 31(12):767-802. PubMed ID: 83406
[TBL] [Abstract][Full Text] [Related]
5. Deoxidized gulose moiety attenuates the pulmonary toxicity of 6'-deoxy-bleomycin Z without effect on its antitumor activity.
Kong J; Xiong Y; Duan Y; Zhu X
Biomed Pharmacother; 2021 Apr; 136():111222. PubMed ID: 33450497
[TBL] [Abstract][Full Text] [Related]
6. [Toxicological studies on pepleomycin sulfate (NK631). VI. Chronic toxicity of pepleomycin in dogs (author's transl)].
Ito K; Handa J; Irie Y; Ezura H; Kumagai M; Irie Y; Suzuki A; Hagiwara T; Yamane H; Miyamoto K; Yamashita T; Tsubosaki M; Matsuda A; Konoha N
Jpn J Antibiot; 1979 Mar; 32(3):387-450. PubMed ID: 86626
[TBL] [Abstract][Full Text] [Related]
7. Deglycosylated bleomycin has the antitumor activity of bleomycin without pulmonary toxicity.
Burgy O; Wettstein G; Bellaye PS; Decologne N; Racoeur C; Goirand F; Beltramo G; Hernandez JF; Kenani A; Camus P; Bettaieb A; Garrido C; Bonniaud P
Sci Transl Med; 2016 Feb; 8(326):326ra20. PubMed ID: 26888428
[TBL] [Abstract][Full Text] [Related]
8. [Toxicological studies on pepleomycin sulfate (NK631), IV. Chronic toxicity of pepleomycin sulfate in rats (author's transl)].
Tsubosaki M; Irie Y; Ito K; Handa J; Ezura H; Kumagai M; Irie Y; Suzuki A; Yamashita T; Miyamoto K; Matsuda A; Konoha N
Jpn J Antibiot; 1978 Dec; 31(12):803-36. PubMed ID: 83407
[TBL] [Abstract][Full Text] [Related]
9. [Toxicological studies on pepleomycin sulfate (NK 631) II. Subacute toxicity of pepleomycin sulfate in rats (author's transl)].
Tsubosaki M; Irie Y; Ito K; Handa J; Ezura H; Kumagai M; Irie Y; Suzuki A; Yamashita T; Miyamoto K; Matsuda A; Konoha N
Jpn J Antibiot; 1978 Dec; 31(12):738-65. PubMed ID: 83405
[TBL] [Abstract][Full Text] [Related]
10. [Absorption, excretion, distribution and metabolism of 3H-labelled pepleomycin sulfate (author's transl)].
Takayama H; Itoh M; Mizuguchi S; Abuki H; Ishibashi M; Miyazaki H
Jpn J Antibiot; 1978 Dec; 31(12):895-909. PubMed ID: 83412
[TBL] [Abstract][Full Text] [Related]
11. [Toxicological studies on pepleomycin sulfate (NK 631). I. Acute toxicity of pepleomycin in mice, rats and dogs (author's transl)].
Ito K; Irie Y; Miyamoto K; Yamashita T; Tsubosaki M; Matsuda A; Konoha N
Jpn J Antibiot; 1978 Dec; 31(12):719-37. PubMed ID: 83404
[TBL] [Abstract][Full Text] [Related]
12. Tallysomycin S10b: experimental antitumor activity and toxicity.
Schurig JE; Rose WC; Hirth RS; Schlein A; Huftalen JB; Florczyk AP; Bradner WT
Cancer Chemother Pharmacol; 1984; 13(3):164-70. PubMed ID: 6207948
[TBL] [Abstract][Full Text] [Related]
13. Potentiation of antitumor effect of bleomycin by lipid-surfactant mixed micelles. I. In vivo and tumor-neutralizing activity against mouse Ehrlich ascites tumor and rat ascites hepatoma AH66.
Yoshikawa H; Takada K; Muranishi S
J Pharmacobiodyn; 1985 Apr; 8(4):305-10. PubMed ID: 2411907
[TBL] [Abstract][Full Text] [Related]
14. [Ultrastructural alterations of rat ventral prostate after peplomycin sulfate administration (author's transl)].
Okada K; Yamamoto T; Gon H; Kishimoto T
Jpn J Antibiot; 1981 Aug; 34(8):1196-201. PubMed ID: 6172609
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the pulmonary toxicity and chemotherapeutic activity of bleomycin-BAPP to bleomycin and pepleomycin.
Ginsburg E; Gram TE; Trush MA
Cancer Chemother Pharmacol; 1984; 12(2):111-5. PubMed ID: 6199131
[TBL] [Abstract][Full Text] [Related]
16. [Derivative of bleomycin generates less of ROS? Less of fibrosis? Alternative in the development of an efficacy anticancer therapy but less toxic].
Brahim S; Bettaieb A; Kenani A
Bull Cancer; 2010 May; 97(5):527-34. PubMed ID: 20100681
[TBL] [Abstract][Full Text] [Related]
17. Effect of erythrocytes on alveolar macrophage cytostatic activity induced by bleomycin lung damage in rats.
Huot AE; Gundel RM; Hacker MP
Cancer Res; 1990 Apr; 50(8):2351-5. PubMed ID: 1690596
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen sulfide protects against bleomycin-induced pulmonary fibrosis in rats by inhibiting NF-κB expression and regulating Th1/Th2 balance.
Cao H; Zhou X; Zhang J; Huang X; Zhai Y; Zhang X; Chu L
Toxicol Lett; 2014 Jan; 224(3):387-94. PubMed ID: 24269241
[TBL] [Abstract][Full Text] [Related]
19. Bleomycin-induced pulmonary fibrosis is independent of eosinophils.
Hao H; Cohen DA; Jennings CD; Bryson JS; Kaplan AM
J Leukoc Biol; 2000 Oct; 68(4):515-21. PubMed ID: 11037973
[TBL] [Abstract][Full Text] [Related]
20. In vivo circumvention of human colon carcinoma resistance to bleomycin.
Jani JP; Mistry JS; Morris G; Davies P; Lazo JS; Sebti SM
Cancer Res; 1992 May; 52(10):2931-7. PubMed ID: 1374681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
